Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07144306
AI-Driven Early Detection of Skin Cancer
Sponsor: Nuvana Healthcare LTD
View on ClinicalTrials.gov
Summary
This study evaluates the feasibility and accuracy of an AI-powered mobile platform (NuvanaDx) for early detection of skin cancer, including melanoma, using smartphone-based imaging. The platform is designed to improve access to early diagnosis, reduce waiting times, and support triage into appropriate care pathways.
Key Details
Gender
All
Age Range
18 Months - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2025-10-01
Completion Date
2026-01-01
Last Updated
2025-09-26
Healthy Volunteers
Yes
Conditions
Interventions
DIAGNOSTIC_TEST
Smartphone-based AI skin lesion analysis (NuvanaDx platform).
Smartphone-based AI skin lesion analysis (NuvanaDx platform).
Locations (1)
Nuvana Healthcare Ltd
London, United Kingdom